CYCLOGYL CYCLOPEN OCUPENTOLATE

Dose: 0.5 mg
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Ophthalmic
Instructions: Repeated after 5 min

Dose: 0.5 mg
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Opthalmic
Instructions: Once or repeated in 5min as required

Dose: 0.5 mg
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Opthalmic
Instructions: Once or repeated in 5min as required

. It is of Synthetic origin and belongs to Phenyl Acetate. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Opthalmic Products pharmacological group.The Molecular Weight of Cyclopentolate (HCl) is 327.80.

Cyclopentolate (HCl) is contraindicated in conditions like Narrow-angle glaucoma.

The severe or irreversible adverse effects of Cyclopentolate (HCl), which give rise to further complications include Convulsions, Disturbance of speech.The symptomatic adverse reactions produced by Cyclopentolate (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Ataxia, Restlessness, Allergic reactions, Hallucination, Psychosis, Hyperactivity, Loss of accomodation, Increased IOP, Vision disturbances, Burning sensation.

Cyclopentolate (HCl) is primarily indicated in conditions like Diagnostic aid for mydriasis and cycloplegia.

No data regarding the interactions of Cyclopentolate (HCl) was found.

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Eye Drops Store in a well closed container.

It should be used with caution in elderly patients and other patients who may be predisposed to increased intraocular pressure, hypersensitivity to belladonna alkaloids, synechiae, Downs syndrome. Cyclopentolate 2% solution may result in psychotic reactions and behavioral disturbances in children, usually occurring approximately 30-45 minutes after instillation. It is classified as pregnancy category C and should be used with caution during pregnancy only if clearly needed.